New, fast corroding high ductility Mg–Bi–Ca and Mg–Bi–Si alloys, with no clinically observable gas formation in bone implants

Abstract Current approaches to initial corrosion rate reduction of biodegradable magnesium alloys include alloying with rare earth elements, mechanical processing, coatings and the use of metallic glasses. The latter has limited ductility needed for implant adaptively to various surgery procedures. Furthermore, slow corroding magnesium alloys, coatings or metallic glasses have not proved to be fully dissolvable in vivo. With this in mind, we have developed a new class of biocompatible, biodegradable ductile magnesium alloys with 40% elongation at room temperature. The alloys are based on the Mg–Bi system and undergo a series of production routes, which include rapid solidification (RS) and various extrusion processes. The Mg–Bi–Si (B-BS) system exhibited a high corrosion rates in vitro and was excluded from in vivo screening. In preliminary experiments of Mg–Bi–Ca (B-BX) in rabbit femur bones, the alloy corroded rapidly without any clinically visible gas formation. Only 30% of the B-BX implant remained uncorroded after 4 weeks of implantation. After using low iron Mg for implant preparation the corrosion rate of HP-B-BX was reduced in bone leaving 70% of the implant uncorroded after 4 weeks, while the corrosion in intramuscular and subcutaneous sites were still high leaving only 40% and 10% uncorroded after 4 weeks. The foreign body reaction was very mild and enhanced bone formation could be observed in the vicinity of the corroding implant. Thus, these new magnesium alloys are potentially promising biomaterials, although more detailed in vivo studies need to be performed in actual implant situations.

[1]  Frank Witte,et al.  Degradable biomaterials based on magnesium corrosion , 2008 .

[2]  H. Satoh,et al.  A 13‐Week Toxicity Study of Bismuth in Rats by Intratracheal Intermittent Administration , 2005, Journal of occupational health.

[3]  Gunnar F. Nordberg,et al.  Handbook on the Toxicology of Metals , 1979 .

[4]  F. Beckmann,et al.  In vivo corrosion and corrosion protection of magnesium alloy LAE442. , 2010, Acta biomaterialia.

[5]  Frank Witte,et al.  The history of biodegradable magnesium implants: a review. , 2010, Acta biomaterialia.

[6]  M. Störmer,et al.  Biodegradable magnesium-hydroxyapatite metal matrix composites. , 2007, Biomaterials.

[7]  M. Escudero,et al.  Corrosion behaviour of AZ31 magnesium alloy with different grain sizes in simulated biological fluids. , 2010, Acta biomaterialia.

[8]  E. Willbold,et al.  Biodegradable magnesium scaffolds: Part II: peri-implant bone remodeling. , 2007, Journal of biomedical materials research. Part A.

[9]  P. Uggowitzer,et al.  MgZnCa glasses without clinically observable hydrogen evolution for biodegradable implants. , 2009, Nature materials.

[10]  H. Haferkamp,et al.  In vivo corrosion of four magnesium alloys and the associated bone response. , 2005, Biomaterials.

[11]  Frank Witte,et al.  In vitro and in vivo corrosion measurements of magnesium alloys. , 2006, Biomaterials.

[12]  A. Hirner,et al.  Determination of Trimethylbismuth in the Human Body after Ingestion of Colloidal Bismuth Subcitrate , 2009, Drug Metabolism and Disposition.

[13]  J. Nellesen,et al.  Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling. , 2010, Acta biomaterialia.

[14]  E. Willbold,et al.  Biodegradable magnesium scaffolds: Part 1: appropriate inflammatory response. , 2007, Journal of biomedical materials research. Part A.

[15]  M. Mabuchi,et al.  Review Processing and mechanical properties of fine-grained magnesium alloys , 1999 .

[16]  H. Satoh,et al.  Oral Toxicity of Bismuth in Rat: Single and 28‐Day Repeated Administration Studies , 2005, Journal of occupational health.

[17]  A. Bussiba,et al.  Grain refinement of AZ31 and ZK60 Mg alloys — towards superplasticity studies , 2001 .